GPT HealthcareNSE:GPTHEALTH -1.61%43 EBITDA Margin % is 19.78% as of Mar. 2026, which is 12% below its 10-year median of 22.46. GuruFocus rates NSE:GPTHEALTH with a GF Score™ of 43/100. The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, GPT Healthcare ranks better than 71.71% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. GPT Healthcare's EBITDA for the
three
months ended in Mar. 2026 was ₹250 Mil. GPT Healthcare's Revenue for the
three
months ended in Mar. 2026 was ₹1,264 Mil. Therefore, GPT Healthcare's EBITDA margin for the quarter that ended in Mar. 2026 was 19.78%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
GPT Healthcare EBITDA Margin % Related Terms
GPT Healthcare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for GPT Healthcare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:GPTHEALTH vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, GPT Healthcare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GPT Healthcare EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GPT Healthcare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where GPT Healthcare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GPT Healthcare (NSE:GPTHEALTH) has a EBITDA Margin % of 19.78% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on GPT Healthcare and its competitors. This is 12% below median its historical median of 22.46. Over the past decade, GPT Healthcare's EBITDA Margin % has ranged from 19.07 to 23.16. According to the industry distribution chart, GPT Healthcare ranks #189 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 28.3%.
Is GPT Healthcare's EBITDA Margin % too high?
GPT Healthcare's current EBITDA Margin % of 19.78% is 12% below median its 10-year median of 22.46. Over the past 10 years, this metric has ranged from a low of 19.07 to a high of 23.16. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. GPT Healthcare's value of 19.78% is 93.7% above this industry median. Based on the distribution chart, GPT Healthcare ranks #189 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, GPT Healthcare has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does GPT Healthcare's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, GPT Healthcare ranks #189 out of 668 companies for EBITDA Margin %. This puts GPT Healthcare in the upper half of its industry. The industry median EBITDA Margin % is 10.21. GPT Healthcare's value of 19.78% is 93.7% above this benchmark. Historically, GPT Healthcare's own EBITDA Margin % has ranged from 19.07 to 23.16 over the past decade. While the company's 10-year median is 22.46 vs. the industry median of 10.21, GPT Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GPT Healthcare's current EBITDA Margin % of 19.78% is 93.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on GPT Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GPT Healthcare's current EBITDA Margin % is 19.78%, which is 12% below median its own 10-year median of 22.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GPT Healthcare stock overvalued right now?
GPT Healthcare (NSE:GPTHEALTH) has a current EBITDA Margin % of 19.78%. The current EBITDA Margin % is 19.78%, which is 12% below median its 10-year median of 22.46 and 93.7% above the Healthcare Providers & Services industry median of 10.21. GPT Healthcare's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For GPT Healthcare (NSE:GPTHEALTH), the current EBITDA Margin % is 19.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GPT Healthcare Ltd is engaged in the healthcare sector. It operates a chain of mid-sized full-service hospitals under the ILS brand. It provides integrated healthcare services, with a focus on secondary and tertiary care and operates four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of approximately 561 beds. It offers a comprehensive range of healthcare services across over 35 specialities and super specialities, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.
43GF Score
Get the complete analysis for NSE:GPTHEALTH
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GPTHEALTH has been successfully added to your 
